Reveals effective identification of cryptic binding sites using mixed solvent simulations in drug discovery, indicating broader targeting potential.
structures. Here, we developed and validated a novel "induce-and-identify" workflow that integrates mixed solvent molecular dynamics (MxMD) simulations with SiteMap. This approach leverages MxMD to sample protein conformations to expose hidden pockets, which are then effectively identified and ranked by SiteMap. Using a challenging data set of 65 cryptic binding sites, the developed workflow identified the cryptic binding site within the top 5 predictions in 78.5% of cases. These results suggest that the proposed MxMD + SiteMap workflow provides a robust and valuable tool for early phase drug discovery, enabling the exploration of a broader range of druggable targets by effectively inducing and identifying cryptic binding sites.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: